Glaxosmithkline | Bénéfice Avant Impôts



Pre Tax Profit Changement Date
AbbVie USD 1.66B 3.15B 2025-03
Amgen USD 1.57B 405M 2025-06
AstraZeneca USD 3.13B 275M 2025-06
Aurora Cannabis CAD 32.07M 31.47M 2024-12
Bausch Health Companies USD 140M 187M 2025-06
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Canopy Growth CAD -121580000 9.67M 2024-12
Corcept Therapeutics USD 31.69M 22.07M 2025-06
Drreddys Laboratories 18.74B 431M 2024-12
Eli Lilly USD 6.78B 3.32B 2025-06
GlaxoSmithKline GBP 1.89B 221M 2025-06
Glaxosmithkline USD 1.66B 1.78B 2024-12
J&J USD 13.63B 8.21B 2025-03
Merck USD 6.77B 864M 2025-06
Novartis USD 4.53B 124M 2025-06
Pacira USD -1927000 10.63M 2025-06
Perrigo USD 3.2M 5.1M 2025-06
Pfizer USD 3.04B 259M 2025-06
Prestige Brands USD 61.78M 12.18M 2025-06
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 1.42B 734M 2025-06
Supernus Pharmaceuticals USD 16.67M 22.5M 2025-06
Takeda JPY 150.63B 257.93B 2025-06
Teva Pharmaceutical Industries USD 203M 91M 2025-06
Zoetis USD 902M 92M 2025-06


Glaxosmithkline Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.